-
Enhancing chimeric antigen receptor T-cell therapy for hematological malignancies through split-signaling CAR T-cells
van der Schans, J. J., 13 Jan 2026, 220 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL
van der Horst, H. J., Csikós, T., Quik, M., van der Schans, J. J., de Lint, K., Nuñez Moreno, G., Guan, M., Karagoz, K., Breij, E. C. W., Santegoets, K. C. M., Chamuleau, M. E. D., Roukens, M. G., Overdijk, M. B. & Mutis, T., 1 Dec 2025, In: Blood Cancer Journal. 15, 1, 156.Research output: Contribution to journal › Article › Academic › peer-review
-
Emerging strategies in CAR-T cell therapy for acute myeloid leukemia: overcoming heterogeneity and improving safety through dual-antigen targeting
Ocaña-Cara, Á., Mutis, T. & van der Schans, J. J., 1 Dec 2025, In: Experimental Hematology and Oncology. 14, 1, 135.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
